share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4：持股變動聲明-高管 Marriott Tina
美股SEC公告 ·  07/30 06:20
牛牛AI助理已提取核心訊息
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on July 25, 2024. The transaction was executed at a price of $8.1349 per share, resulting in a total market value of $48,809.40. Prior to this sale, Marriott exercised an equivalent number of shares at a price of $1.06 each. Following the transactions, Marriott's direct holdings in Recursion Pharmaceuticals amount to 535,457 shares.
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on July 25, 2024. The transaction was executed at a price of $8.1349 per share, resulting in a total market value of $48,809.40. Prior to this sale, Marriott exercised an equivalent number of shares at a price of $1.06 each. Following the transactions, Marriott's direct holdings in Recursion Pharmaceuticals amount to 535,457 shares.
Recursion Pharmaceuticals的總裁兼首席運營官Tina Marriott於2024年7月25日出售了公司6,000股A類普通股，每股價格爲8.1349美元，總市值爲48,809.40美元。在此次出售之前，Marriott以每股1.06美元的價格行使了相同數量的股票。經過這些交易後，Marriott在Recursion Pharmaceuticals的直接持股數爲535,457股。
Recursion Pharmaceuticals的總裁兼首席運營官Tina Marriott於2024年7月25日出售了公司6,000股A類普通股，每股價格爲8.1349美元，總市值爲48,809.40美元。在此次出售之前，Marriott以每股1.06美元的價格行使了相同數量的股票。經過這些交易後，Marriott在Recursion Pharmaceuticals的直接持股數爲535,457股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。